Sejong Medical Co., Ltd.

KOSDAQ:A258830 Stock Report

Market Cap: ₩23.0b

Sejong Medical Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Byungsung Kim

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure1.4yrs
CEO ownershipn/a
Management average tenureno data
Board average tenureno data

Recent management updates

No updates

Recent updates

Sejong Medical (KOSDAQ:258830) Might Be Having Difficulty Using Its Capital Effectively

Mar 24
Sejong Medical (KOSDAQ:258830) Might Be Having Difficulty Using Its Capital Effectively

Update: Sejong Medical (KOSDAQ:258830) Stock Gained 53% In The Last Year

Mar 02
Update: Sejong Medical (KOSDAQ:258830) Stock Gained 53% In The Last Year

Does The Market Have A Low Tolerance For Sejong Medical Co., Ltd.'s (KOSDAQ:258830) Mixed Fundamentals?

Feb 11
Does The Market Have A Low Tolerance For Sejong Medical Co., Ltd.'s (KOSDAQ:258830) Mixed Fundamentals?

We're Not Counting On Sejong Medical (KOSDAQ:258830) To Sustain Its Statutory Profitability

Jan 27
We're Not Counting On Sejong Medical (KOSDAQ:258830) To Sustain Its Statutory Profitability

Is Sejong Medical Co., Ltd. (KOSDAQ:258830) A Smart Choice For Dividend Investors?

Jan 12
Is Sejong Medical Co., Ltd. (KOSDAQ:258830) A Smart Choice For Dividend Investors?

Income Investors Should Know That Sejong Medical Co., Ltd. (KOSDAQ:258830) Goes Ex-Dividend Soon

Dec 25
Income Investors Should Know That Sejong Medical Co., Ltd. (KOSDAQ:258830) Goes Ex-Dividend Soon

Should We Be Excited About The Trends Of Returns At Sejong Medical (KOSDAQ:258830)?

Dec 23
Should We Be Excited About The Trends Of Returns At Sejong Medical (KOSDAQ:258830)?

These 4 Measures Indicate That Sejong Medical (KOSDAQ:258830) Is Using Debt Reasonably Well

Dec 08
These 4 Measures Indicate That Sejong Medical (KOSDAQ:258830) Is Using Debt Reasonably Well

The Sejong Medical (KOSDAQ:258830) Share Price Has Gained 42% And Shareholders Are Hoping For More

Nov 19
The Sejong Medical (KOSDAQ:258830) Share Price Has Gained 42% And Shareholders Are Hoping For More

CEO

Byungsung Kim (54 yo)

1.4yrs

Tenure

Byungsung Kim serves as Chief Executive Officer at Sejong Medical Co., Ltd. since 2023. Byungsung Kim served as Representative Director at Sejong Medical Co., Ltd.